{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T20:43:21Z","timestamp":1788641001301,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Australian Government Research Training Program Scholarship"},{"name":"NHMRC) Early Career Fellowship Scheme","award":["#1072137"],"award-info":[{"award-number":["#1072137"]}]},{"name":"NHMRC) Early Career Fellowship Scheme","award":["#1091878"],"award-info":[{"award-number":["#1091878"]}]},{"name":"NHMRC Dementia Leadership Fellowship","award":["#1140298"],"award-info":[{"award-number":["#1140298"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.sapharm.2018.07.001","type":"journal-article","created":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T14:20:18Z","timestamp":1530627618000},"page":"925-935","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Harms associated with extramedical use of prescription opioid analgesics in Australia: A scoping review"],"prefix":"10.1016","volume":"15","author":[{"given":"Samanta","family":"Lalic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natali","family":"Jokanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenni","family":"Ilom\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasa","family":"Gisev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan I.","family":"Lubman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Simon","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sapharm.2018.07.001_bib1","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.pain.2004.09.019","article-title":"Opioids in chronic non-cancer pain: systematic review of efficacy and safety","volume":"112","author":"Kalso","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.sapharm.2018.07.001_bib2","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1185\/030079905X65321","article-title":"Impact of long-term use of opioids on quality of life in patients with chronic, non-malignant pain","volume":"21","author":"Devulder","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.sapharm.2018.07.001_bib3","doi-asserted-by":"crossref","first-page":"276","DOI":"10.7326\/M14-2559","article-title":"The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop","volume":"162","author":"Chou","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.sapharm.2018.07.001_bib4","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/S0140-6736(16)00161-6","article-title":"Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study","volume":"387","author":"Berterame","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.sapharm.2018.07.001_bib5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1465-3362.2011.00292.x","article-title":"Trends over time in characteristics of pharmaceutical drug-related ambulance attendances in Melbourne","volume":"30","author":"Lloyd","year":"2011","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.sapharm.2018.07.001_bib6","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMp1011512","article-title":"A flood of opioids, a rising tide of deaths","volume":"363","author":"Okie","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.sapharm.2018.07.001_bib7","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1503\/cmaj.090784","article-title":"Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone","volume":"181","author":"Dhalla","year":"2009","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.sapharm.2018.07.001_bib8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.drugalcdep.2017.07.018","article-title":"Trends in heroin and pharmaceutical opioid overdose deaths in Australia","volume":"179","author":"Roxburgh","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.sapharm.2018.07.001_bib9","doi-asserted-by":"crossref","first-page":"ES191","DOI":"10.36076\/ppj.2012\/15\/ES191","article-title":"Prescription opioid related misuse, harms, diversion and interventions in Canada: a review","volume":"15","author":"Fischer","year":"2012","journal-title":"Pain Physician"},{"key":"10.1016\/j.sapharm.2018.07.001_bib10","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1089\/pop.2013.0098","article-title":"Prescription opioid abuse: a literature review of the clinical and economic burden in the United States","volume":"17","author":"Meyer","year":"2014","journal-title":"Popul Health Manag"},{"key":"10.1016\/j.sapharm.2018.07.001_bib11","first-page":"1","article-title":"Drug-poisoning deaths involving opioid analgesics: United States, 1999-2011","author":"Chen","year":"2014","journal-title":"NCHS (Natl. Cent. Health Stat.) Adv. NCHS Data"},{"key":"10.1016\/j.sapharm.2018.07.001_bib12","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","article-title":"Increases in drug and opioid-involved overdose deaths - United States, 2010-2015","volume":"65","author":"Rudd","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.sapharm.2018.07.001_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060600","article-title":"Characteristics of opioid-users whose death was related to opioid-toxicity: a population-based study in Ontario, Canada","volume":"8","author":"Madadi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.sapharm.2018.07.001_bib14","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1556-4029.2011.01703.x","article-title":"Toxicology and characteristics of fatal oxycodone toxicity cases in New South Wales, Australia 1999-2008","volume":"56","author":"Darke","year":"2011","journal-title":"J Forensic Sci"},{"key":"10.1016\/j.sapharm.2018.07.001_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12024-014-9624-x","article-title":"An update on oxycodone: lessons for death investigators in Australia","volume":"11","author":"Pilgrim","year":"2015","journal-title":"Forensic Sci Med Pathol"},{"key":"10.1016\/j.sapharm.2018.07.001_bib16","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.forsciint.2013.01.028","article-title":"A review of methadone deaths between 2001 and 2005 in Victoria, Australia","volume":"226","author":"Pilgrim","year":"2013","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.sapharm.2018.07.001_bib17","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/j.1360-0443.2010.03014.x","article-title":"The global diversion of pharmaceutical drugs: opiate treatment and the diversion of pharmaceutical opiates: a clinician's perspective","volume":"105","author":"Bell","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.sapharm.2018.07.001_bib18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13011-017-0120-7","article-title":"Chronic pain and opioid misuse: a review of reviews","volume":"12","author":"Voon","year":"2017","journal-title":"Subst Abuse Treat Prev Pol"},{"key":"10.1016\/j.sapharm.2018.07.001_bib19","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1465-3362.2010.00283.x","article-title":"Definitions related to the use of pharmaceutical opioids: extramedical use, diversion, non-adherence and aberrant medication-related behaviours","volume":"30","author":"Larance","year":"2011","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.sapharm.2018.07.001_bib20","doi-asserted-by":"crossref","first-page":"280","DOI":"10.5694\/mja10.11450","article-title":"Prescription of opioid analgesics and related harms in Australia","volume":"195","author":"Roxburgh","year":"2011","journal-title":"Med J Aust"},{"key":"10.1016\/j.sapharm.2018.07.001_bib21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/bcp.12937","article-title":"Twenty-five years of prescription opioid use in Australia: a whole-of-population analysis using pharmaceutical claims","volume":"82","author":"Karanges","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.sapharm.2018.07.001_bib22","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/jrsm.1123","article-title":"A scoping review of scoping reviews: advancing the approach and enhancing the consistency","volume":"5","author":"Pham","year":"2014","journal-title":"Res Synth Meth"},{"key":"10.1016\/j.sapharm.2018.07.001_bib23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.drugalcdep.2015.02.038","article-title":"The introduction of a potentially abuse deterrent oxycodone formulation: Early findings from the Australian National Opioid Medications Abuse Deterrence (NOMAD) study","volume":"151","author":"Degenhardt","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.sapharm.2018.07.001_bib24","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/pme.12295","article-title":"Changes in prevalence of prescription opioid abuse after introduction of an abuse-deterrent opioid formulation","volume":"15","author":"Cassidy","year":"2014","journal-title":"Pain Med"},{"key":"10.1016\/j.sapharm.2018.07.001_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011062","article-title":"Impact of long-term opioid use for chronic non-cancer pain onmisuse, abuse or addiction, overdose, falls and fractures","author":"Furlan","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.sapharm.2018.07.001_bib26","first-page":"42","article-title":"Doctor shopping: a phenomenon of many themes","volume":"9","author":"Sansone","year":"2012","journal-title":"Innov. Clin. Neurosci."},{"key":"10.1016\/j.sapharm.2018.07.001_bib27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jsat.2015.06.001","article-title":"The characteristics of a cohort who tamper with prescribed and diverted opioid medications","volume":"58","author":"Larance","year":"2015","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.sapharm.2018.07.001_bib28","first-page":"13","article-title":"Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and incidence data","author":"Munn","year":"2015","journal-title":"Int J Evid Base Healthc"},{"key":"10.1016\/j.sapharm.2018.07.001_bib29","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.drugpo.2010.04.004","article-title":"Gender differences in hepatitis C antibody prevalence and risk behaviours amongst people who inject drugs in Australia 1998-2008","volume":"21","author":"Iversen","year":"2010","journal-title":"Int J Drug Pol"},{"key":"10.1016\/j.sapharm.2018.07.001_bib30","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/1753-6405.12032","article-title":"Healthcare utilisation and disclosure of injecting drug use among clients of Australia's needle and syringe programs","volume":"37","author":"Islam","year":"2013","journal-title":"Aust N Z J Publ Health"},{"key":"10.1016\/j.sapharm.2018.07.001_bib31","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/09595230600868504","article-title":"Trends in morphine prescriptions, illicit morphine use and associated harms among regular injecting drug users in Australia","volume":"25","author":"Degenhardt","year":"2006","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.sapharm.2018.07.001_bib32","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.addbeh.2015.01.034","article-title":"Motivations, substance use and other correlates amongst property and violent offenders who regularly inject drugs","volume":"45","author":"Sutherland","year":"2015","journal-title":"Addict Behav"},{"key":"10.1016\/j.sapharm.2018.07.001_bib33","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/0310057X1504300117","article-title":"A retrospective survey of substance abuse in anaesthetists in Australia and New Zealand from 2004 to 2013","volume":"43","author":"Fry","year":"2015","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.sapharm.2018.07.001_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugpo.2016.12.004","article-title":"High risk injecting behaviour among people who inject pharmaceutical opioids in Australia","volume":"42","author":"Iversen","year":"2017","journal-title":"Int J Drug Pol"},{"key":"10.1016\/j.sapharm.2018.07.001_bib35","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.drugalcdep.2017.02.027","article-title":"Frequency and severity of non-fatal opioid overdoses among clients attending the Sydney Medically Supervised Injecting Centre","volume":"176","author":"Roxburgh","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.sapharm.2018.07.001_bib36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.drugpo.2016.12.007","article-title":"Pharmaceutical opioid use among oral and intravenous users in Australia: a qualitative comparative study","volume":"41","author":"Dertadian","year":"2017","journal-title":"Int J Drug Pol"},{"key":"10.1016\/j.sapharm.2018.07.001_bib37","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.drugalcdep.2014.01.023","article-title":"Circumstances and toxicology of sudden or unnatural deaths involving alprazolam","volume":"138","author":"Darke","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.sapharm.2018.07.001_bib38","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/add.12930","article-title":"The health consequences of injecting tablet preparations: foreign body pulmonary embolization and pulmonary hypertension among deceased injecting drug users","volume":"110","author":"Darke","year":"2015","journal-title":"Addiction"},{"key":"10.1016\/j.sapharm.2018.07.001_bib39","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/dar.12033","article-title":"Trends in fentanyl prescriptions and fentanyl-related mortality in Australia","volume":"32","author":"Roxburgh","year":"2013","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.sapharm.2018.07.001_bib40","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.drugpo.2016.08.004","article-title":"Risk of fentanyl overdose among clients of the Sydney medically supervised injecting centre","volume":"37","author":"Latimer","year":"2016","journal-title":"Int J Drug Pol"},{"issue":"S1","key":"10.1016\/j.sapharm.2018.07.001_bib41","doi-asserted-by":"crossref","first-page":"S203","DOI":"10.1111\/dar.12617","article-title":"Pharmaceutical opioid use and harm in Australia: the need for proactive and preventative responses","volume":"37","author":"Larance","year":"2018","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.sapharm.2018.07.001_bib42","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.sapharm.2016.11.005","article-title":"Behavioral, mental, and physical health characteristics and opioid medication misuse among community pharmacy patients: a latent class analysis","volume":"13","author":"Cochran","year":"2017","journal-title":"Res Soc Adm Pharm"},{"issue":"6","key":"10.1016\/j.sapharm.2018.07.001_bib43","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/pm\/pnx035","article-title":"Prescription opioid access patterns and factors associated with increasing number of prescribers, pharmacies, and dispensings: an observational study using pharmaceutical claims","volume":"19","author":"Blanch","year":"2018","journal-title":"Pain Med"},{"key":"10.1016\/j.sapharm.2018.07.001_bib44","series-title":"Real-time Prescription Monitoring Victoria: Victoria State Government","year":"2016"},{"key":"10.1016\/j.sapharm.2018.07.001_bib45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.drugalcdep.2015.02.010","article-title":"Abrupt decline in oxycodone-caused mortality after implementation of Florida's Prescription Drug Monitoring Program","volume":"150","author":"Delcher","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.sapharm.2018.07.001_bib46","series-title":"Joanna Briggs Institute Reviewers' Manual: 2016 Edition","author":"The Joanna Briggs Institute","year":"2016"},{"key":"10.1016\/j.sapharm.2018.07.001_bib47","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0376-8716(98)00028-3","article-title":"Self-report among injecting drug users: a review","volume":"51","author":"Darke","year":"1998","journal-title":"Drug Alcohol Depend"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741118302845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741118302845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:16:09Z","timestamp":1761556569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741118302845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1551741118302845"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2018.07.001","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Harms associated with extramedical use of prescription opioid analgesics in Australia: A scoping review","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2018.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}